Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2018 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

2 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Isolation and characterization of living primary astroglial cells using the new GLAST-specific monoclonal antibody ACSA-1.
Jungblut M, Tiveron MC, Barral S, Abrahamsen B, Knöbel S, Pennartz S, Schmitz J, Perraut M, Pfrieger FW, Stoffel W, Cremer H, Bosio A. Jungblut M, et al. Glia. 2012 May;60(6):894-907. doi: 10.1002/glia.22322. Epub 2012 Feb 28. Glia. 2012. PMID: 22374709
Progress in defining astrocyte subpopulations has been hampered by the lack of a suitable antibody for their direct detection and isolation. Here, we describe a new monoclonal antibody, ACSA-1, which was generated by immunization of GLAST1 knockout mice. ...Using an …
Progress in defining astrocyte subpopulations has been hampered by the lack of a suitable antibody for their direct detection and isolati
Endophytic Fungus Isolated From Achyrocline satureioides Exhibits Selective Antiglioma Activity-The Role of Sch-642305.
Pedra NS, Galdino KCA, da Silva DS, Ramos PT, Bona NP, Soares MSP, Azambuja JH, Canuto KM, de Brito ES, Ribeiro PRV, Souza ASQ, Cunico W, Stefanello FM, Spanevello RM, Braganhol E. Pedra NS, et al. Front Oncol. 2018 Oct 29;8:476. doi: 10.3389/fonc.2018.00476. eCollection 2018. Front Oncol. 2018. PMID: 30420941 Free PMC article.
Glioblastoma is the most devastating primary brain tumor. Current treatment is palliative, making necessary the development of new therapeutic strategies to offer alternatives to patients. ...However, there are no reports describing the endophytic composition of A. …
Glioblastoma is the most devastating primary brain tumor. Current treatment is palliative, making necessary the development of new